Assessing Short-term Treatment Satisfaction and Quality of Life in Patients With Hidradenitis Suppurativa Initiated on Secukinumab.
Clinical trial NCT06785675 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06785675
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-10
- Primary completion
- 2026-10-10
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.